Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Shores Medical Associates
852
mi
from
St. Clair Shores, MI
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Shores Medical Associates
852
mi
from
St. Clair Shores, MI
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Montana Medical Research, Inc.
1037
mi
from
Missoula, MT
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Montana Medical Research, Inc.
1037
mi
from
Missoula, MT
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Clinical Research of South Nevada
958
mi
from
Las Vegas, NV
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Clinical Research of South Nevada
958
mi
from
Las Vegas, NV
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Aloha Medical Center
960
mi
from
Las Vegas, NV
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Aloha Medical Center
960
mi
from
Las Vegas, NV
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
LA Sight
1168
mi
from
Los Angeles, CA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
LA Sight
1168
mi
from
Los Angeles, CA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Clinical Research Advantage, Inc.
967
mi
from
Las Vegas, NV
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Clinical Research Advantage, Inc.
967
mi
from
Las Vegas, NV
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Independent Clinical Researchers
961
mi
from
Las Vegas, NV
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Independent Clinical Researchers
961
mi
from
Las Vegas, NV
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
AB Clinical Trials
961
mi
from
Las Vegas, NV
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
AB Clinical Trials
961
mi
from
Las Vegas, NV
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Edison Medical Group
1266
mi
from
Edison, NJ
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Edison Medical Group
1266
mi
from
Edison, NJ
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Family Health Medical Services PLLC
1016
mi
from
Mayville, NY
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Family Health Medical Services PLLC
1016
mi
from
Mayville, NY
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Medical Frontiers
738
mi
from
Carlisle, OH
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Medical Frontiers
738
mi
from
Carlisle, OH
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Community Research and Sleep Management
722
mi
from
Crestview Hills, KY
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Community Research and Sleep Management
722
mi
from
Crestview Hills, KY
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Hightop Medical Research Center
724
mi
from
Cincinnati, OH
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Hightop Medical Research Center
724
mi
from
Cincinnati, OH
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Rapid Medical Research, Inc.
903
mi
from
Cleveland, OH
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Rapid Medical Research, Inc.
903
mi
from
Cleveland, OH
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Parsons Avenue Medical Center
812
mi
from
Columbus, OH
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Parsons Avenue Medical Center
812
mi
from
Columbus, OH
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
North Star Medical Research
888
mi
from
Cleveland, OH
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
North Star Medical Research
888
mi
from
Cleveland, OH
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Pharmacotherpy Research Associates Inc
863
mi
from
Zanesville, OH
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Pharmacotherpy Research Associates Inc
863
mi
from
Zanesville, OH
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
COR Clinical Research
157
mi
from
Oklahoma City, OK
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
COR Clinical Research
157
mi
from
Oklahoma City, OK
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Sooner Clinical Research
154
mi
from
Oklahoma City, OK
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Sooner Clinical Research
154
mi
from
Oklahoma City, OK
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Fanno Creek Clinic
1384
mi
from
Portland, OR
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Fanno Creek Clinic
1384
mi
from
Portland, OR
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Omega Medical Research
1420
mi
from
Warwick, RI
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Omega Medical Research
1420
mi
from
Warwick, RI
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Hartwell Research Group
875
mi
from
Anderson, SC
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Hartwell Research Group
875
mi
from
Anderson, SC
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
DeGarmo Institute of Medical Research
887
mi
from
Greer, SC
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
DeGarmo Institute of Medical Research
887
mi
from
Greer, SC
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Pain Specialists of Charleston
1055
mi
from
North Charleston, SC
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Pain Specialists of Charleston
1055
mi
from
North Charleston, SC
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Health Concepts
521
mi
from
Rapid City, SD
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Health Concepts
521
mi
from
Rapid City, SD
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
InvestiClin Research
621
mi
from
Brentwood, TN
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
InvestiClin Research
621
mi
from
Brentwood, TN
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
SCRI Research Center
481
mi
from
Germantown, TN
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
SCRI Research Center
481
mi
from
Germantown, TN
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Prevention & Strengthening Solutions, Inc.
510
mi
from
Humboldt, TN
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Prevention & Strengthening Solutions, Inc.
510
mi
from
Humboldt, TN
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
FutureSearch Clinical Trials
513
mi
from
Austin, TX
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
FutureSearch Clinical Trials
513
mi
from
Austin, TX
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Galenos Research
339
mi
from
Northeast, TX
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Galenos Research
339
mi
from
Northeast, TX
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Pillar Clinical Research, LLC
339
mi
from
Dallas, TX
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Pillar Clinical Research, LLC
339
mi
from
Dallas, TX
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
FutureSearch Clinical Trials, LP
342
mi
from
Dallas, TX
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
FutureSearch Clinical Trials, LP
342
mi
from
Dallas, TX
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
KRK Medical Research
340
mi
from
Dallas, TX
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
KRK Medical Research
340
mi
from
Dallas, TX
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Pioneer Research Solutions, Inc.
570
mi
from
Houston, TX
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Pioneer Research Solutions, Inc.
570
mi
from
Houston, TX
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Clinical Trial Network
572
mi
from
Houston, TX
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Clinical Trial Network
572
mi
from
Houston, TX
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Sun Research Institute
575
mi
from
San Antonio, TX
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Sun Research Institute
575
mi
from
San Antonio, TX
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Pioneer Research Solutions
578
mi
from
Sugar Land, TX
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Pioneer Research Solutions
578
mi
from
Sugar Land, TX
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Spring Clinical Research
575
mi
from
Sugarland, TX
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Spring Clinical Research
575
mi
from
Sugarland, TX
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
LIfestyle Prosthetics & Orthotics
1442
mi
from
North Andover, MA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
LIfestyle Prosthetics & Orthotics
1442
mi
from
North Andover, MA
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
ACR Research Salt Lake City
782
mi
from
West Jordan, UT
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
ACR Research Salt Lake City
782
mi
from
West Jordan, UT
Ulimorelin Study of Efficacy and Safety (ULISES 008)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous (IV) Ulimorelin Administered Post-Operatively to Accelerate Recovery of Gastrointestinal (GI) Motility in Subjects Who Have Undergone Partial Bowel Resection
Status: Archived
MultiCare Research Institute
1408
mi
from
Tacoma, WA
Ulimorelin Study of Efficacy and Safety (ULISES 008)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous (IV) Ulimorelin Administered Post-Operatively to Accelerate Recovery of Gastrointestinal (GI) Motility in Subjects Who Have Undergone Partial Bowel Resection
Status: Archived
Updated: 1/1/1970
MultiCare Research Institute
1408
mi
from
Tacoma, WA
Comparative Study of Biologic Mesh Versus Repair With Component Separation.
Randomized Control Trial of Biologic Mesh (XenMATRIXTM) vs. Component Separation Alone in Contaminated Ventral Hernia Repair:a Pilot Study
Status: Archived
Case Western Reserve Univ
899
mi
from
Cleveland, OH
Comparative Study of Biologic Mesh Versus Repair With Component Separation.
Randomized Control Trial of Biologic Mesh (XenMATRIXTM) vs. Component Separation Alone in Contaminated Ventral Hernia Repair:a Pilot Study
Status: Archived
Updated: 1/1/1970
Case Western Reserve Univ
899
mi
from
Cleveland, OH
Ulimorelin Study of Efficacy and Safety (ULISES 007)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous (IV) Ulimorelin Administered Post-Operatively to Accelerate Recovery of Gastrointestinal (GI) Motility in Subjects Who Have Undergone Partial Bowel Resection
Status: Archived
CRC of Jackson
572
mi
from
Jackson, MS
Ulimorelin Study of Efficacy and Safety (ULISES 007)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous (IV) Ulimorelin Administered Post-Operatively to Accelerate Recovery of Gastrointestinal (GI) Motility in Subjects Who Have Undergone Partial Bowel Resection
Status: Archived
Updated: 1/1/1970
CRC of Jackson
572
mi
from
Jackson, MS
Efficacy Study of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) Versus Lactulose in Patients With Hepatic Encephalopathy.
Randomized Controlled Trial Evaluating the Efficacy of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) in Patients With Hepatic Encephalopathy.
Status: Archived
UT Soutwestern Medical Center at Dallas
345
mi
from
Dallas, TX
Efficacy Study of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) Versus Lactulose in Patients With Hepatic Encephalopathy.
Randomized Controlled Trial Evaluating the Efficacy of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) in Patients With Hepatic Encephalopathy.
Status: Archived
Updated: 1/1/1970
UT Soutwestern Medical Center at Dallas
345
mi
from
Dallas, TX
Clinical Trial to Assess Safety of SI-6603 in Patients With Lumbar Disc Herniation
An Open Label, Non-randomized Dose-escalation Study to Assess Safety and Tolerability of SI-6603 in Patients With Lumbar Disc Herniation (Phase II Study)
Status: Archived
SKK
1139
mi
from
Encinitas, CA
Clinical Trial to Assess Safety of SI-6603 in Patients With Lumbar Disc Herniation
An Open Label, Non-randomized Dose-escalation Study to Assess Safety and Tolerability of SI-6603 in Patients With Lumbar Disc Herniation (Phase II Study)
Status: Archived
Updated: 1/1/1970
SKK
1139
mi
from
Encinitas, CA
Pharyngocise Dose Response Study
Muscle Preservation and Swallow Function Following Radiotherapy: A Dose Response Study
Status: Archived
University of Florida Gainesville
1049
mi
from
Gainesville, FL
Pharyngocise Dose Response Study
Muscle Preservation and Swallow Function Following Radiotherapy: A Dose Response Study
Status: Archived
Updated: 1/1/1970
University of Florida Gainesville
1049
mi
from
Gainesville, FL
Pharmacokinetics of Tasimelteon in Subjects With Mild or Moderate Hepatic Impairment
An Open-Label, Single-Dose, Parallel-Group Study to Compare the Pharmacokinetics of Tasimelteon With That in Matched Healthy Control Subjects
Status: Archived
Orlando Clinical Research Center
1144
mi
from
Orlando, FL
Pharmacokinetics of Tasimelteon in Subjects With Mild or Moderate Hepatic Impairment
An Open-Label, Single-Dose, Parallel-Group Study to Compare the Pharmacokinetics of Tasimelteon With That in Matched Healthy Control Subjects
Status: Archived
Updated: 1/1/1970
Orlando Clinical Research Center
1144
mi
from
Orlando, FL
Trenev Trio/Healthy Trinity for Symptoms of Diarrhea-predominant Irritable Bowel Syndrome (IBS) and Functional Dyspepsia
A Double-blind, Randomized, Placebo-controlled, Dual-center Study on the Effect of Healthy Trinity (Retail Label)/Trenev Trio (Professional Label) on Symptoms of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) and Functional Dyspepsia
Status: Archived
In-Quest Medical Research, LLC
806
mi
from
Suwanee-Duluth, GA
Trenev Trio/Healthy Trinity for Symptoms of Diarrhea-predominant Irritable Bowel Syndrome (IBS) and Functional Dyspepsia
A Double-blind, Randomized, Placebo-controlled, Dual-center Study on the Effect of Healthy Trinity (Retail Label)/Trenev Trio (Professional Label) on Symptoms of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) and Functional Dyspepsia
Status: Archived
Updated: 1/1/1970
In-Quest Medical Research, LLC
806
mi
from
Suwanee-Duluth, GA
Trenev Trio/Healthy Trinity for Symptoms of Diarrhea-predominant Irritable Bowel Syndrome (IBS) and Functional Dyspepsia
A Double-blind, Randomized, Placebo-controlled, Dual-center Study on the Effect of Healthy Trinity (Retail Label)/Trenev Trio (Professional Label) on Symptoms of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) and Functional Dyspepsia
Status: Archived
Clinical Research Associates of Tidewater
1181
mi
from
Norfolk, VA
Trenev Trio/Healthy Trinity for Symptoms of Diarrhea-predominant Irritable Bowel Syndrome (IBS) and Functional Dyspepsia
A Double-blind, Randomized, Placebo-controlled, Dual-center Study on the Effect of Healthy Trinity (Retail Label)/Trenev Trio (Professional Label) on Symptoms of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) and Functional Dyspepsia
Status: Archived
Updated: 1/1/1970
Clinical Research Associates of Tidewater
1181
mi
from
Norfolk, VA
The Effect of a Meal on Vitamin D Absorption
Meal Effects on the 25OHD3 Response to Supplemental Vitamin D3
Status: Archived
Jean Mayer USDA Human Nutrition Research Center on Aging
1444
mi
from
Boston, MA
The Effect of a Meal on Vitamin D Absorption
Meal Effects on the 25OHD3 Response to Supplemental Vitamin D3
Status: Archived
Updated: 1/1/1970
Jean Mayer USDA Human Nutrition Research Center on Aging
1444
mi
from
Boston, MA